Overview
Zhengwei Dong practices in Shanghai, China. Dong is rated as an Advanced expert by MediFind in the treatment of Pleural Effusion. Their top areas of expertise are Pleural Effusion, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Pleural Effusion.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pleural EffusionDong isAdvanced. Learn about Pleural Effusion.
- Experienced
- EGFR Positive Lung CancerDong isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDong isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDong isExperienced. Learn about Lung Cancer.
- MosaicismDong isExperienced. Learn about Mosaicism.
- Non-Small Cell Lung Cancer (NSCLC)
- PleurisyDong isExperienced. Learn about Pleurisy.